Foley Represents The Dermatology Group in its Sale to The Riverside Company
08 January 2016
Foley & Lardner LLP provided strategic counsel to firm client The Dermatology Group in its sale to The Riverside Company in a private transaction. The sale closed on December 31, 2015.
The Dermatology Group, located throughout Eastern New Jersey is the premier destination for innovative, comprehensive solutions to address a variety of dermatologic concerns. The Dermatology Group offers a complete menu of clinical and cosmetic services to cover all aspects of medical, surgical, and cosmetic dermatology. The Riverside Company is a worldwide private equity firm focused on investing in growing small and medium-sized enterprises.
The Foley team was led by Partners Roger Strode, Steven M. Gerenraich and John B. Palmer III. The extended deal team included Partners Jana Kolarik Anderson, Mike H. Woolever, Alan D. Rutenberg and Richard W. Lasater; Senior Counsel Monica R. Chmielewski, and Benjamin R. Dryden; and Associates Melesa A. Freerks, Taylor E. Whitten, and Melissa D. Conroy.
The Dermatology Group, located throughout Eastern New Jersey is the premier destination for innovative, comprehensive solutions to address a variety of dermatologic concerns. The Dermatology Group offers a complete menu of clinical and cosmetic services to cover all aspects of medical, surgical, and cosmetic dermatology. The Riverside Company is a worldwide private equity firm focused on investing in growing small and medium-sized enterprises.
The Foley team was led by Partners Roger Strode, Steven M. Gerenraich and John B. Palmer III. The extended deal team included Partners Jana Kolarik Anderson, Mike H. Woolever, Alan D. Rutenberg and Richard W. Lasater; Senior Counsel Monica R. Chmielewski, and Benjamin R. Dryden; and Associates Melesa A. Freerks, Taylor E. Whitten, and Melissa D. Conroy.
People
Related News
18 December 2024
Press Releases
Foley Names Jen Cafferty Patton as Chief Operating Officer to Further Drive Strategic Growth and Business Performance
Foley & Lardner LLP is pleased to announce Jen Cafferty Patton has been promoted to Chief Operating Officer to bolster the firm’s administrative leadership and advance its strategic priorities.
11 December 2024
Press Releases
Foley Releases Guide to Navigate Issues Stemming from Rapid Expansion of Antibody Drug Conjugates
Foley & Lardner LLP today released Antibody Drug Conjugates Keep Growing: What You Need to Know, a guide that answers many business and legal questions about the rapid expansion of this area of technology.
11 December 2024
Press Releases
Foley Expands East Coast Presence with IP Partner Brian Tomkins, Strengthening Capabilities in Technology and Health Care Sectors
Foley & Lardner LLP announced today that the firm has bolstered its Innovative Technology and Health Care & Life Sciences Sectors with the addition of Brian Tomkins as a partner in the Mechanical & Electromechanical Technologies Practice Group.